– Valeant Pharmaceuticals Archives

Press ESC key to close search

Going Automatic: Exploring Technology Trends of 2022 and Beyond

In a roundtable with asset-based lending technology experts from Lendscape, Solifi, ABL Soft and Codix, ABF Journal explores the most recent trends in the ABL technology arena, including real time data sharing, artificial intelligence and software-as-a-service solutions.

Valeant Seeking Refi of Existing Credit Agreement

Valeant Pharmaceuticals is seeking to amend and restate its existing credit agreement, agented by Barclays, and borrow $3.815 billion of new term B loans.

May 14, 2018 – Valeant Pharmaceuticals | Barclays ABF Journal

Valeant Seeking Refi of Existing Credit Agreement

Valeant Pharmaceuticals is seeking to amend and restate its existing credit agreement, agented by Barclays, and borrow $3.815 billion of new term B loans.

May 11, 2018 – Valeant Pharmaceuticals | Barclays ABF Journal

Barclays Arranges Valeant Pharmaceuticals Amendment

Valeant Pharmaceuticals has arranged an amendment to its credit facility in exchange for a higher interest rate and a fee. Barclay’s served as arranger for the transaction.

August 22, 2016 – Valeant Pharmaceuticals | Barclays Bank ABF Journal

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: – Valeant Pharmaceuticals

Going Automatic: Exploring Technology Trends of 2022 and Beyond

Valeant Seeking Refi of Existing Credit Agreement

Valeant Seeking Refi of Existing Credit Agreement

Barclays Arranges Valeant Pharmaceuticals Amendment